Agomab raised $100m in Series C funding led by Fidelity, joined by EQT, Canaan Partners and KKR-controlled Dawn Biopharma

Biotech Health services

Investments

05 October 2023

Agomab (company)

Biotech Health services

Total investments received (USD): 303.5m

Round value (USD): 100m

Round investors: EQT Partners Fidelity Investments Canaan Partners Dawn Biopharma

Company: Agomab

Industry: Biotech Health services

Biotech Health services Pharma

Secondary 21 March 2024

Biotech Health services

Investments 03 March 2024

Biotech Health services

Investments 06 November 2023

CRM Software Services

Investments 22 June 2023

Biotech Health services Pharma

Investments 06 June 2023